Replies to post #64217 on NorthWest Biotherapeutics Inc (NWBO)

[DoGood_DoWell]

(1) Not buying the argument that regulators have forbade them from releasing positive information.
(2) Despite the hold and cessation of recruitment, the amount of money that flows to Cognate has barely ebbed. Why?
(3) Patents themselves are sheltered off somewhere
(4) Had assets safely been secured within the company, the stock would be trading much higher.
(5) if NWBO goes bankrupt, Cognate will continue to exist so with all the money paid, they are rich is cash, and have ALL the manufacturing capacity and knowledge and capability on making DCVAX.

More reasons that OL is incorrect:

There are other reasons other than being forbidden by regulators to disclose that the company might not want to be silent

As has been previously disclosed, manufacturing is being built, developed and optimized.

Patents being used as collateral seem to be evidence that the company is not trying to go bankrupt, as they are trying to protect the viability of the key assets

Absolutely no proof of #4

Outside Lane is not privy to Cognate's books, so #5 is just bluster.